Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat

Area of Science:

• Nephrology
• Endocrinology
• Bone Biology

Background:

• Idiopathic hypercalciuria is a common cause of kidney stones.
• Genetic hypercalciuric stone-forming (GHS) rats serve as a valuable animal model for human hypercalciuria.
• Understanding the pathophysiology of hypercalciuria is crucial for developing effective treatments.

Purpose of the Study:

• To review the insights gained from studying GHS rats regarding hypercalciuria.
• To explore the pathophysiology and consequences of hypercalciuria using the GHS rat model.
• To discuss the implications for human clinical hypercalciuria.

Main Methods:

• Review of existing literature on GHS rats.
• Analysis of calcium transport mechanisms in GHS rats.
• Assessment of bone mineral density and vitamin D receptor expression.

Main Results:

• GHS rats exhibit systemic calcium transport dysregulation, including increased intestinal absorption and bone resorption, and decreased renal reabsorption.
• Elevated vitamin D receptor levels in the intestine, bone, and kidney mediate these changes, increasing tissue sensitivity to vitamin D.
• GHS rats show reduced bone mineral density, which is worsened by vitamin D but improved by thiazide diuretics.

Conclusions:

• GHS rats offer a unique model for investigating hypercalciuria, urine supersaturation, and stone formation.
• This model allows for direct study of dietary and pharmacologic interventions on stone disease and bone health.
• Findings in GHS rats provide a basis for understanding and treating clinical hypercalciuria in humans.